Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Biomerica Stock Quote

Biomerica (NASDAQ: BMRA)

$0.68
(-5.3%)
-$0.04
Price as of April 25, 2024, 3:57 p.m. ET

Biomerica Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
BMRA -45.54% -72.09% -22.52% -94%
S&P +24.56% +72.51% +11.52% +3,002%

Biomerica Company Info

Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The firm focuses on gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates through the following geographical segments: Europe, United States, Asia, South America, Middle East, and Other. The company was founded in September 1971 and is headquartered in Irvine, CA.

News & Analysis

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.